|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 329.90 DKK | -1.76% |
|
+2.37% | +1.43% |
| 00:18 | Abbott untersucht zwei separate Cybervorfälle, nach eigenen Angaben keine Auswirkungen auf den Betrieb | RE |
| 17.07. | Novo Nordisk bringt günstigere Ozempic-Kopie in Südafrika auf den Markt | RE |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.38% | 3.29% | 14.7x | 6.49x | 5.5x | 11.33x | 13.22x | 227 Mrd. | ||
| 0.58% | 0.64% | 34.75x | 20.82x | 12.42x | 25.87x | 26.87x | 1’043 Mrd. | ||
| 2.15% | 2.25% | 26.86x | 6.72x | 6.13x | 16.78x | 18.44x | 602 Mrd. | ||
| 2.7% | 2.84% | 33.14x | 12662.52x | 7.52x | 15.43x | 15.94x | 449 Mrd. | ||
| 3.02% | 3.09% | 17.71x | 6.56x | 4.39x | 10.82x | 12.17x | 327 Mrd. | ||
| 2.89% | 2.98% | 21.31x | 6.14x | 5.47x | 13.24x | 14.48x | 279 Mrd. | ||
| 1.96% | 2.07% | 21.26x | 4.98x | 4.48x | 12.39x | 13.4x | 264 Mrd. | ||
| 2.71% | 2.87% | 24.37x | 18.75x | 6.42x | 11.35x | 14.71x | 201 Mrd. | ||
| 2.38% | 2.47% | -49.1x | 8.6x | 5.86x | 32.41x | 64.88x | 169 Mrd. | ||
| 6.86% | 6.94% | 12.77x | 1.63x | 3.12x | 7.88x | 8.91x | 143 Mrd. | ||
| 4.16% | 4.24% | 11.75x | 5.31x | 3.22x | 8.67x | 9.32x | 124 Mrd. | ||
| -.--% | -.--% | 27.8x | 5.57x | 8.4x | 18.93x | 19.84x | 123 Mrd. | ||
| 5.53% | 5.86% | 11.61x | 1.23x | 2.17x | 6.97x | 7.93x | 106 Mrd. | ||
| 3.56% | 3.75% | 12.39x | 4.51x | 2.75x | 7.94x | 9.1x | 105 Mrd. | ||
| 1.89% | 2.17% | 23.41x | 5.31x | 7.92x | 14.97x | 15.67x | 73.36 Mrd. | ||
| 0.48% | 0.54% | 40.1x | 5.4x | 9.09x | 30.06x | 31.16x | 54.49 Mrd. | ||
| 0.48% | 1.32% | 20.63x | 1.67x | 1.73x | 8.19x | 13.75x | 53.63 Mrd. | ||
| 3.82% | 3.91% | 43.01x | 1.15x | 2.66x | 9.41x | 26.91x | 51.98 Mrd. | ||
| 2.16% | 2.4% | 19.11x | 1.93x | 3.47x | 13.01x | 14.6x | 43.95 Mrd. | ||
| -.--% | -.--% | 37.39x | 17.78x | 6.23x | 28.31x | 27.37x | 37.8 Mrd. | ||
| Durchschnitt | 2.54% | 2.68% | 20.25x | 639.65x | 5.45x | 15.20x | 18.93x | 223.87 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.25% | 2.35% | 23.07x | 1’280.37x | 7.10x | 17.03x | 19.68x |
- Börse
- Aktien
- A3EU6F Aktie
- Sektor Novo Nordisk A/S
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















